TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 2 | 3 | 36 | 32 | 31 | -46 | 10 |
| P | %wins | 100 | 100 | 100 | 100 | 100 | 0 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/31/18 18:59 | 5/29/18 | VKTX | Viking Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Webster Stephen W | CA | D | P | 42 | 5.21 | 0 | 8 | New | 8 | D | |||||||||||||||
5/23/18 20:37 | 5/23/18 | NBRV | Nabriva Therapeutics Plc | L2 | Health | Drug | Pharmaceutical Preparations | Webster Stephen W | PA | D | P | 37 | 4.59 | 0 | 8 | New | 8 | D | |||||||||||||||
2/6/15 16:46 | 2/4/15 | ONCE | Spark Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Webster Stephen W | PA | O | CFO | P | 58 | 23.00 | 16 | 3 | New | 3 | D | -8 | 2 | 3 | 36 | 32 | 31 | -46 | |||||||
6/27/11 16:08 | 6/27/11 | ADLR | Adolor Corp | Health | Drug | Pharmaceutical Preparations | Webster Stephen W | PA | O | SVP,Fina | P | 19 | 1.88 | 0 | 10 | 8 | 138 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |